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Contribution of the Highly Conserved EaeH Surface Protein to
Enterotoxigenic Escherichia coli Pathogenesis
Alaullah Sheikh,a Qingwei Luo,b Koushik Roy,d Salwa Shabaan,e Pardeep Kumar,b Firdausi Qadri,f James M. Fleckensteina,b,c
Molecular Microbiology and Microbial Pathogenesis Program, Division of Biology and Biomedical Sciences,a and Department of Medicine,b Washington University School
of Medicine, St. Louis, Missouri, USA; Medicine Service, Veterans Affairs Medical Center, St. Louis, Missouri, USAc; Medicine Service, Veterans Affairs Medical Center,
Memphis, Tennessee, USAd; Department of Microbiology and Immunology, Faculty of Pharmacy, Beni-Sueif University, Beni-Sueif, Egypte; Immunology Laboratory,
International Centre for Diarrhoeal Disease Research, Mohakhali, Dhaka, Bangladeshf
Enterotoxigenic Escherichia coli (ETEC) strains are among the most common causes of diarrheal illness worldwide. These patho-
gens disproportionately afflict children in developing countries, where they cause substantial morbidity and are responsible for
hundreds of thousands of deaths each year. Although these organisms are important targets for enteric vaccines, most develop-
ment efforts to date have centered on a subset of plasmid-encoded fimbrial adhesins known as colonization factors and heat-
labile toxin (LT). Emerging data suggest that ETEC undergoes considerable changes in its surface architecture, sequentially de-
ploying a number of putative adhesins during its interactions with the host. We demonstrate here that one putative highly
conserved, chromosomally encoded adhesin, EaeH, engages the surfaces of intestinal epithelial cells and contributes to bacterial
adhesion, LT delivery, and colonization of the small intestine.
Infectious diarrhea continues to cause tremendous suffering indeveloping countries, resulting in an estimated one to two mil-
lion deaths each year. Enterotoxigenic Escherichia coli (ETEC)
contributes significantly to premature deaths from diarrheal ill-
ness in young children (1, 2) and causes substantial morbidity in
surviving children and adults (3). ETEC strains are perennially the
leading etiology of diarrhea in travelers to areas where ETEC
strains are endemic (4).
By definition, these organisms secrete heat-labile (LT) and/or
heat-stable (ST) enterotoxins that induce host cell production of
cyclic nucleotides (cyclic AMP [cAMP] and cGMP, respectively)
to activate protein kinases that ultimately result in phosphoryla-
tion of the cystic fibrosis transmembrane regulatory channel
(CFTR) (5–7) and Na ion exchangers (8) on the surfaces of in-
testinal epithelial cells. Ensuing chloride secretion through CFTR,
as well as the commensurate loss of salt and water into the intes-
tinal lumen, results in the cholera-like watery diarrhea character-
istic of ETEC infections (9).
In the current paradigm for ETEC pathogenesis, this organism
must effectively colonize the small intestine to deliver LT and/or
ST efficiently. The majority of pathogenesis (10–12) and molecu-
lar epidemiology (13) studies, as well as subsequent vaccine devel-
opment efforts (14, 15), have focused primarily on plasmid-en-
coded fimbrial colonization factors (CFs), which are felt to be
critical for colonization of the small intestine.
This longstanding but fairly simple view of ETEC pathogenesis
inwhich bacteria adhere via CFs to the small intestine, where these
pathogens release their toxin(s), likely underestimates the com-
plexity of these pathogens. More recent investigations have high-
lighted a number of novel putative virulence factors (16, 17),
unique interactions of ETEC with the epithelium (18–20), and an
intricate orchestration of multiple pathogen-host events (21) that
culminate in successful toxin delivery to epithelial cell targets (22).
Collectively, the emerging data suggest that these sophisticated
interactions of ETEC strains with their host might be exploited in
outlining novel strategies for vaccine development (23).
Unfortunately, despite ETEC’s global importance, several ob-
stacles need to be surmounted in order to develop a broadly pro-
tective ETEC vaccine (15, 24). One central challenge to ETEC
vaccinology is the general plasticity of E. coli genomes (25). Al-
though CFs remain the most extensively studied ETEC vaccine
targets (15, 26), they are not universally conserved (27), with at
least 26 antigenically distinct structures (15, 28) that vary consid-
erably by time and geography (13). ETEC infections in young
children in developing countries appear to provide substantive
protection against subsequent diarrheal illness caused by these
organisms (2, 29, 30). However, epidemiologic studies (29, 31), as
well as recent vaccine trials (32), suggest that other antigens may
be involved in protection. Therefore, over time it has become
apparent that additional strategies are needed to complement a
CF-based approach to ETEC vaccines.
Interestingly, recent studies of ETEC transcriptional modula-
tion following interaction with epithelial cells highlighted a num-
ber of genes potentially encoding novel target antigens (21). One
gene, eaeH, which was strongly upregulated upon epithelial cell
attachment, was originally identified in ETEC by subtractive hy-
bridization with a laboratory strain of E. coli (33). Although our
earlier studies suggested that eaeH encodes a surface-expressed
antigen that is expressed in the context of epithelial cells (21), its
role in the pathogenesis of ETEC has not been explored. The pres-
ent studies were undertaken to examine the role of this highly
conserved antigen in ETEC bacterium-host interaction and toxin
delivery.
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Bacterial strains and growth conditions. A complete list of bacterial
strains used or generated during the course of these studies is provided in
Table 1. Bacteria were grown at 37°C in Luria broth supplemented with
antibiotics as appropriate from frozen glycerol stocks maintained at
80°C.
Bioinformatic analysis of EaeH. SignalP (3.0) (34) (http://www.cbs
.dtu.dk/services/SignalP/) was used to identify a putative signal peptide
region of EaeH, and PSORTb (v3.0 [http://www.psort.org/]) (35) was
used to determine the possible subcellular location of the protein.
Searches for regions of homology with intimin were performed compar-
ing the intimin (eaeA gene product, GenBank accession number
P19809.2) sequence from EPEC against the H10407 genome. Domains
within EaeH fromH10407 were identified in the Conserved Domain Da-
tabase using the domain-enhanced lookup time-accelerated BLAST
(DELTA-BLAST) algorithm.
Mutagenesis, cloning, and expression of eaeH.To construct an eaeH
deletion mutant, the primers jf062612.9 and jf062612.10 (Table 2) were
first used to amplify a kanamycin resistance cassette from pKD4 with
60-bp tails corresponding to the DNA sequence immediately upstream
and downstream of eaeH. The resulting amplicon was then introduced
into H10407 carrying the pKD46 helper plasmid to affect lambda red-
mediated homologous recombination to generate the mutant as previ-
ously described (36).
To construct an eaeH expression plasmid, the primers jf051010.1 (5=-
GGGGACAAGTTTGTACAAAAAAGCAGGCTggGAAGGAGATAGAA
CCATGTCACATTATAAAACAGGT-3=) and jf051010.2 (5=-GGGGACC
ACTTTGTACAAGAAAGCTGGGTcTGGCATCTCCTCCTCGCCA
TT-3=) (Table 2) were first used to amplify a 4,254-bp eaeH gene fragment
(lacking only the stop codon) fromH10407 genomic DNA. The resulting
amplicon, containing 5= and 3= terminal attB sites, was then cloned by
bacteriophage lambda-mediated recombination with corresponding attP
sites on pDONR221, yielding pSS001. After we confirmed the construc-
tion of pSS001, this plasmid was recombined with pET-DEST42 placing
the eaeH gene in-frame with C-terminal V5 and polyhistidine tags to
create the pSS002 expression plasmid. The eaeH gene with its native stop
codon was also amplified from H10407 genomic DNA using the primers
jf020112.3 and 020112.4 (Table 2), digested with HindIII and BglII, and
TABLE 1 Bacterial strains and plasmids




H10407 ETEC; serotype O78:H11; LT STh STp Bangladesh, 1973 (10)
E24377A ETEC; serotype O139:H28;CFA/II (CS1/CS3); LT/ST Egypt (58)
Juruá 18/11, 20/10 ETEC associated with severe cholera-like diarrhea; CS7; LT Amazon (59)
2726950 ETEC; CS21; ST; mild, self-limited diarrhea isolate ICDDR,Bb; 2007
2785200 ETEC; CF LT; 2007 severe cholera-like disease ICDDR,B; 2007
2845650 ETEC; CS4/CS6 LT/ST; mild, self-limited diarrhea ICDDR,B; 2008
2860650 ETEC; CS5CS6 LT/ST; severe cholera-like disease ICDDR,B; 2008
2864350 ETEC; CF LT/ST; severe cholera-like disease ICDDR,B; 2008
2875150 ETEC; CS4/CS6 LT/ST; severe cholera-like disease ICDDR,B; 2008
BCE034_MS14 ETEC; CFA/I ST; 2003 asymptomatic colonization ICDDR,B 2003
P0299917.2 LT/ST-H; severe cholera-like disease ICDDR,B; 2011
BCE001_MS16 CF LT; asymptomatic colonization ICDDR,B; 2004
MG1655 E. coli K-12 (F  ilvG rfb-50 rph-1); serotype OR:H48:K University of
Wisconsin
HS E. coli from healthy laboratory scientist, WRAIR 60
Nissle 1917 E. coli O6:K5:H1 commensal strain isolated from a German soldier in 1917 61, 62
jf876 lacZYA::Kmr mutant of H10407 49
jf2852 eaeH::Kmr This study
NiCo21(DE3) can::CBD fhuA2 [lon] ompT gal ( DE3) [dcm] arnA::CBD slyD::CBD glmS6 ala hsdS  DE3 
sBamHIo EcoRI-B int::(lacI::PlacUV5::T7 gene1) i21 nin-5
New England Biolabs
BL21AI F ompT hsdS B (rB
mB
) gal dcm araB::T7RNAP- tetA 19
Top10 FmcrA (mrr-hsdRMS-mcrBC) 80lacZM15 lacX74 recA1 araD139 (ara-leu)7697 galU galK
rpsL (Strr) endA1 nupG 
Invitrogen
Plasmids
pDONR221 Entry cloning plasmid containing ccdB negative selection gene and Cmr cassette between lambda attP
sites for recombination with PCR products containing attB regions; Kmr
Invitrogen
pET-DEST42 T7 lac promoter/IPTG-inducible expression plasmid; ccdB, Cmr genes flanked by attR sites for
recombination with entry plasmid; C-terminal V5 and His6 tags
Invitrogen
pSS001 4,254-bp eaeH amplicon cloned into pDONOR221 This study
pSS002 EaeH expression plasmid derived from LR recombination reaction of pSS001 and pET-DEST42
placing eaeH in frame with V5 and His6 epitope tags
This study
pAS004 4,257-bp eaeH amplicon with native stop codon cloned into HindIII-BglII sites on pFLAG-CTC This study
pKD46 Arabinose-inducible  red recombinase helper plasmid; Ampr; Ts 36
pKD4 Template plasmid for mutagenesis using FRT-Kmr cassettes; Kmr Ampr; oriR 36
pFLAG-CTC 5,348-bp tac promoter expression plasmid for the construction of C-terminal FLAG epitope fusions Sigma
a Kmr, kanamycin resistant; Ampr, ampicillin resistant; Cmr, chloramphenicol resistant; Strr, streptomycin resistant; V5, V5 epitope (GKPIPNPLLGLDST); His6, polyhistidine tag.
FLAG indicates the FLAG (DYKDDDDK) epitope tag. Ts, temperature-sensitive replicon; FRT, FLP recombinase\recognition target; oriR, pir-dependent origin of replication.
WRAIR, Walter Reed Army Institute of Research.
b ICDDR,B, International Center for Diarrheal Disease Research, Bangladesh.
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then directionally cloned into the corresponding sites on pFLAG-CTC
yielding pAS004. Genomic DNA was purified by using aWizard genomic
DNA purification kit (Promega, WI).
Recombinant protein production. The pSS002 expression plasmid
encoding the EaeH-V5-6His fusion protein was introduced into BL21AI
(Table 1), and recombinants were selected on ampicillin (100 	g/ml).
After the induction of BL21AI(pSS002) with IPTG (isopropyl-
-D-thio-
galactopyranoside), recombinant polyhistidine-tagged proteinwas recov-
ered from bacterial lysates (B-PER, bacterial protein extraction reagent;
Pierce/Thermo Scientific) by nickelmetal affinity chromatography.West-
ern blotting with monoclonal antibody against the V5 epitope (-Gly-Lys-
Pro-Ile-Pro-Asn-Pro-Leu-Leu-Gly-Leu-Asp-Ser-Thr-) was then used to
confirm expression of the fusion protein.
Outer membrane preparations. Previously described methods were
used to prepare outer membranes from ETECH10407 or recombinant E.
coli expressing eaeH (19, 37). Briefly, clarified bacterial lysates, prepared in
a French pressure cell, were layered onto a discontinuous gradient pre-
pared from 2.02, 1.44, and 0.78M sucrose in HEPES buffer and subjected
to ultracentrifugation for 16 h at approximately 80,000 g at 4°C. Mate-
rial collected from the 2.02 and 1.44 M interface was diluted 10-fold in
HEPES buffer and recentrifuged at approximately 110,000 g, 4°C for 1
h. The supernatant was discarded, and the resulting outer membrane
preparation was stored at80°C.
Production and purification of polyclonal antibodies. Polyclonal
antisera were produced in rabbits as previously described (16). Briefly,
two New Zealand White rabbits were immunized with recombinant V5-
and polyhistidine-tagged EaeH. The resulting polyclonal antisera were
preabsorbed using an E. coli lysate column (Pierce) and lyophilized strain
AAEC191-A (38). Protein A-agarose (Protein A Plus; Thermo Scientific)
was used to separate antibodies from serum components. Affinity purifi-
cation of antibody against recombinant EaeH (rEaeH)-V5-6His immobi-
lized on nitrocellulose was performed as previously described (18, 39).
Flow cytometry. To identify EaeH on the surface of recombinant E.
coli, BL21AI(pSS002) was grown overnight in a 2 ml of Luria broth con-
taining ampicillin (100	g/ml) at 37°C in a shaking incubator at 250 rpm.
The following day, overnight cultures were diluted 1:100 into freshmedia,
and grown tomid-logarithmic phase (i.e., and optical density at 600 nmof
approximately 0.6 to 0.8). IPTG was added to a final concentration of 0.4
mM, and the cultures were aliquoted into separate tubes, followed by
incubation for an additional 2 h at three different temperatures (37°C,
30°C, and room temperature) with shaking at 250 rpm. Then, 200 	l of
each culture was centrifuged at 10,000  g and 4°C. Strain H10407 was
grown in the same fashion for comparison, omitting the IPTG.
For surface staining, bacterial pellets were washed once with phos-
phate-buffered saline (PBS) and then incubated with 1% bovine serum
albumin (BSA) in PBS for 30min at room temperature. The bacteria were
then incubated with primary antibody (anti-EaeH, rabbit polyclonal an-
tibody or anti-V5 mouse monoclonal antibody) at room temperature for
45 min. After a washing step with PBS, secondary antibody staining was
performed at room temperature in the dark with species-specific antibod-
ies conjugatedwith Alexa Fluor 488 for an additional 45min. The bacteria
were then washed with PBS and resuspended in 500 	l of PBS for acqui-
sition by flow cytometry (FACSCalibur; BD Biosciences). A minimum of
50,000 organism counts were acquired (CellQuest software; Becton Dick-
inson), and the findings were analyzed using FlowJo (v7.6.3).
Binding of EaeH-coated latex beads to Caco-2 intestinal epithelial
cells. rEaeH-V5-6His was adsorbed on the surface of polystyrene latex
beads (1- or 3-	m mean particle size, LB30; Sigma) as described by the
manufacturer. Briefly, 100 	l of aqueous bead suspension (6.8  108
beads) was first prewashed in 25mMMES [2-(N-morpholino)ethanesul-
fonic acid] buffer (pH 6.1), and rEaeH-V5-6His was dialyzed against the
same buffer. The beads were then mixed with the recombinant protein at
a final concentration of 0.4 mg/ml in a total volume of 500 	l containing
0.2% sodium azide overnight at 4°C. Control beads were coatedwith BSA.
After being washed with PBS, the beads were examined by flow cytometry
to document successful adsorption of the rEaeH-V5-6His to the bead
surfaces. Beads were incubated with polyclonal rabbit anti-EaeH sera (1:
1,000), washed and incubated with a 1:200 dilution of fluorescein isothio-
cyanate-conjugated goat anti-rabbit secondary antibody (BD Pharmin-
gen), and then washed and resuspended in PBS for examination using a
four-color dual-laser flow cytometer (FACSCalibur).
Beads coated with rEaeH or control beads were resuspended in 1ml of
tissue culture medium and added to Caco-2 cells grown on glass cover-
slips, whichwere then incubated at 5%CO2 and 37°C. After3 h, the cells
were washed with PBS and fixed with an ice-cold solution of 6% parafor-
maldehyde in PBS. The cells were mounted on glass slides for subsequent
visualization by light microscopy (40, 41). Differential interference con-
trast (DIC) images were obtained on a Zeiss Axiophot microscope by
selecting random fields at 20 from both experimental samples and con-
trols. These were imported into ImageJ (v1.45), and the numbers of beads
TABLE 2 Primers used in this study





jf051010.2 GGGGACCACTTTGTACAAGAAAGCTGGGTcTGGCATCTCCTCCTCGCCATT attB2.reverse.eaeH.[nt: 4234–4254]for C-
terminal fusion in pDET-DEST42
jf050610.1 GGAAAAGGAAATCGGGAAA eaeH locus primer begins 99 bp upstream
from eaeH start codon
jf050610.2 CGTAGAAAAGGATGGCAA eaeH locus primer (reverse) begins 200 bp
downstream and 200 bp from the stop
codon; 4556 amplicon with jf050610.1
jf062612.9 CAGACGCCATTATTTGTGTCTGCCTATGTTCGTTAATTCG
TTCATCAGGAAATTATCTCAGTGTAGGCTGGAGCTGCTTC
60-bp homology tail (bases 1 to 60




eaeHH2 primer bases 4219 to 4254/pKD4.p2
60-bp homology tail (bases 1 to 60
immediately downstream from eaeH), p2
region of pKD4
jf020112.3 ATATCATATGAAGCTAAGCTTATGTCACATTATAAAACAGG HindIII-eaeH (nt 1 to 18); start codon of eaeH
is underlined)
jf020112.4 TGTAGTCGACAGATCAGATCTTTATGGCATCTCCTCCTCGCCA BglII-eaeH (nt 4237 to 4257; the stop codon of
eaeH is underlined)
a The boldfacing and underlining in each sequence are as defined in the final “Description” column. nt, nucleotide(s); attB, bacteriophage lambda recombination sequence.
Contribution of EaeH Protein to ETEC Pathogenesis
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and cells in each image were recorded using the cell counter (ImageJ,
menu Plugins Analyze Cell counter).
Confocal microscopy. To investigate the expression of EaeH in the
context of intestinal epithelial cells, ETEC H10407 was grown overnight
and diluted 1:100 into fresh Luria broth and added at a multiplicity of
infection of 1:100 to Caco-2 cells. Caco-2 cells were seeded approxi-
mately 48 to 72 h prior to infection onto sterile glass coverslips pretreated
with poly-L-lysine. ETEC-infected monolayers were then returned to
37°C and a 5% CO2 atmosphere and removed at various time points for
the removal of infectedmedia and washing. After three washes with tissue
culture media, the cells were fixed with paraformaldehyde, washed with
PBS, and blocked with PBS containing 1% BSA. Affinity-purified anti-
EaeH rabbit polyclonal antibody, followed by Alexa Fluor 488-labeled
anti-rabbit antibody, was then used to identify organisms that expressed
EaeH on the bacterial surface. Intestinal cell membranes were stained as
previously described (CellMask, red; Invitrogen) (18). Images were ac-
quired on a Zeiss LSM510 confocal microscope, and files were converted
to TIFF image using ImageJ (v1.45).
Scanning electron microscopy (SEM).Nonconfluent Caco-2 intesti-
nal epithelial cells were seeded onto coverslips pretreated with poly-L-
lysine, and grown for 24 to 48 h in a 5% CO2 atmosphere at 37°C. Latex
beads (1 or 3	mindiameter; Sigma) coatedwith rEaeHwere added to the
monolayers, followed by incubation for 3 h in tissue culturemedia at 37°C
and 5% CO2. After three gentle washes with PBS, the cells and attached
beads were fixed with 0.1% glutaraldehyde in PBS at room temperature
for 15 min. Coverslips were washed three times with PBS, followed by
subsequent fixation with 3% glutaraldehyde in PBS. The coverslips were
then fixed with 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.35)
for at least 2 h, rinsed (three times for 5min each time) in 0.1Mcacodylate
buffer (pH 7.35), postfixed with 2% osmium tetroxide (pH 7.35; Electron
Microscopy Sciences), and rinsed again with 0.1 M cacodylate buffer,
followedby rinsingwith deionizedwater. The sampleswere stained en bloc
with 2% aqueous uranyl acetate (Electron Microscopy Sciences), rinsed
and dehydrated as previously described in ethyl alcohol (10% through
absolute), and dried in a critical-point dryer replacing the ethanol with
liquid carbon dioxide. Finally, the samples were sputter coated (EMS 550;
Electron Microscopy Sciences) with 60-nm gold palladium. Images were
acquired on a scanning electron microscope (Phillips XL30) and saved as
tiff files.
Bacterial adherence. Caco-2 cells were used to examine ETEC-host
interactions. As described previously (16), adherence assays were per-
formed using semiconfluent Caco-2 cell monolayers seeded into 96-well
tissue culture plates the evening prior to the experiment. Bacteria to be
tested were grown overnight in Luria broth with antibiotics as appropri-
ate, diluted 1:100 the morning of the experiment, and then grown to
approximately mid-logarithmic phase prior to the addition to the mono-
layers. For adherence assays, infected monolayers were incubated at 37°C
and 5% CO2 for 1 h, washed with tissue culture medium four times, and
then lysed in 0.1% Triton X-100 for 5 min, and the bacteria were recov-
ered by plating lysates onto Luria agar.
Heat-labile toxin delivery assays. To examine the role of eaeH in
delivery of heat-labile toxin, ETECH10407 ormutants were used to infect
Caco-2 cells grown to semiconfluence in 96-well plates. After 3 h, the
plateswerewashedwith prewarmed tissue culturemedia, incubated for an
additional 2.5 h, and then lysed and processed for cAMPdetermination by
using an enzyme-linked immunosorbent assay (Arbor Assays) as previ-
ously described (18, 22).
Intestinal colonization studies. To investigate the role of EaeH in
promoting intestinal colonization, mice were challenged with ETEC as
previously described (42). Briefly, after treatment with streptomycin to
eliminate competing flora and famotidine to reduce gastric acidity, CD-1
mice (Charles River) were challenged with strain jf876 (lacZYA::Kmr) or
strain jf2852 (eaeH::Kmr). To determine the number of bacteria directly
attached to the intestinal villi, sections of small intestine were preserved in
10% formalin and embedded in paraffin, and histologic sections were
then processed for confocal immunofluorescence microscopy at the Di-
gestive Diseases Research Core Center (DDRCC) at theWashington Uni-
versity School of Medicine. Competition assays were performed as previ-
ously described (19). Briefly, mice were challenged with 105 CFU of
jf876 and an equal number of jf2852 in a final volume of 400 	l. After 24
h, the mice were sacrificed, and saponin lysates of small intestine were
plated onto agar plates containing kanamycin and X-Gal (5-bromo-4-
chloro-3-indolyl-
-D-galactopyranoside). The numbers of eaeH mutant
bacterial colonies (blue) and eaeHwild-type colonies (white) were used to
calculate the competitive index (CI) for each mouse as follows: CI 
[mutant (blue)/wild type (white)]output CFU/(mutant/wild type)input CFU,
using the input fraction determined at the time of inoculum preparation.
RESULTS
EaeH encodes a surfacemolecule with features shared by bacte-
rial adhesins and invasins. The eaeH gene is predicted to encode
an outer membrane protein with a putative signal sequence at its
amino-terminal end (34, 35), followed by the mature peptide
which shares a region of homology with intimin (EaeA) that cor-
responds to a transmembrane 
-barrel (Fig. 1a) (43). Another
feature shared with intimin (44), invasin (45), and a diverse su-
perfamily of bacterial virulence proteins (46) is a series of tandem
bacterial immunoglobulin-like (BIg) domains similar to those in-
volved in eukaryotic cell surface adhesion proteins such as ICAMs
(47). Partial structural characterization of FdeC (48), the EaeH
homologue from uropathogenic E. coli, appears to be consistent
with this predicted molecular organization.
To examine the surface expression of EaeH in ETEC,we cloned
the full-length eaeH gene from ETEC H10407 in frame with V5
and His6 polyhistidine tags and expressed it in a recombinant E.
coli background (Fig. 1b). Polyclonal antisera raised against EaeH
demonstrated the presence of the protein in the outer membrane
of the recombinant but not in controls from the expression strain
or in ETEC H10407, suggesting that when grown in Luria broth
the expression of EaeH by ETEC is poor. Similarly, the recombi-
nant protein could easily be identified by flow cytometry on the
surface of BL21AI carrying the EaeH-V5-6His expression plas-
mid, using either polyclonal anti-EaeH antibody or with V5
monoclonal antibody, but we were not able to identify significant
amounts of EaeHon the surface ofwild-type ETECwhen grown in
Luria broth (Fig. 1c to e). Together, these results suggest that
whereas eaeH encodes a potential surface-expressed protein, it is
poorly expressed when ETEC is grown in Luria broth.
Surface expression of EaeH is induced on pathogen-epithe-
lial cell interactions. Recent transcriptome analyses of ETEC in
contact with host epithelial cells suggested that eaeH expression is
activated by pathogen-host interactions. Consequently, we exam-
ined the surface expression of the EaeH protein in ETEC and in
nonpathogenic E. coli strains (Fig. 2a) after exposure to media
conditioned by intestinal epithelial cells. Interestingly, we found
that media conditioned by cultured Caco-2 cells was sufficient to
induce the surface expression of EaeH in ETEC (Fig. 2b). In con-
trast, we could not identify EaeH on the surfaces of either strain
MG1655 in which the eaeH gene has been interrupted by an inser-
tion sequence or in the commensal E. coli strain HS, in which the
gene appears to be intact (Table 3), suggesting that ETEC may be
uniquely programmed to respond to host cells by expressing EaeH
in the outer membrane.
Earlier transcriptome studies demonstrated that eaeH expres-
sion is increased following epithelial cell contact (21). Accord-
ingly, we found that shortly after attachment to host cells (5 min,
Sheikh et al.
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Fig. 2c) no EaeH could be identified on the surface ETEC strain
H10407 attached to the surface of Caco-2 cells, whereas at later
time points (60 and 120 min), adherent bacteria were found to
express significant amounts of EaeH on their surfaces. Because
eaeH appears to be highly conserved in ETEC genomes sequenced
to date, we examined whether we could also identify EaeH on the
surfaces of ETEC strain E24377A and other ETEC strains either
following epithelial cell contact (Fig. 2d) or after growth in con-
ditioned media (Fig. 2e). These studies demonstrated that both
eaeH gene and its expression are conserved in ETEC.
EaeH promotes interactions with intestinal epithelial cells.
Based on its structural similarity to known bacterial adhesins and
invasins, EaeHmight be predicted to function in a similar fashion.
After introduction of recombinant EaeH (rEaeH) to cultured in-
testinal epithelial cells, we observed rEaeH decorating the cellular
membrane (Fig. 3a). Likewise, coating latex beads with rEaeH
strongly promoted interaction with Caco-2 intestinal epithelial
cells compared to control BSA-coated beads (Fig. 3b to e). SEM
demonstrated smaller EaeH-coated beads (1 	m) bound to the
surfaces of cells, and some appeared to be partially engulfed by the
host cell (Fig. 3f), whereas larger (3 	m) beads appeared to be
actively engaged by cellular protrusions. Together, these data sug-
gested that EaeH is sufficient to promote epithelial cell interac-
tions.
Similarly, compared to wild-type ETEC, an isogenic eaeHmu-
tant was deficient in adhesion to intestinal epithelial cells in vitro
(Fig. 4a). Likewise, affinity-purified anti-EaeH antisera inhibited
bacteria adhesion in vitro (Fig. 4b), further suggesting that this
highly conserved surface protein plays a role in ETEC pathogen-
host interactions. Earlier studies demonstrated that physical con-
tact of ETEC with epithelial cells is required for effective delivery
of heat-labile toxin (LT) (49). Theoretically, genes that promote
interaction with the intestinal epithelium might also impact the
delivery of LT. In accord with other recently described virulence
factors that affect epithelial cell adhesion (18, 22), eaeH mutants
were impaired in delivery of heat-labile toxin, and antibodies
against this surface protein significantly inhibited bacterial activa-
tion of cAMP in target epithelial cells (Fig. 4c) in vitro.
To examine the potential role of EaeH in intestinal coloniza-
tion, mice were challenged with wild-type and eaeH mutant bac-
teria. In competition assays, in which the total bacteria residing in
lumen of the small intestine were plated onto selective media, we
did not observe a phenotypic difference between wild-type bacte-
ria and the eaeHmutant (Fig. 5a). However, immunofluorescence
(anti-O78)microscopic examination of intestinal mucosa ofmice
infected with either wild-type or the eaeH mutant identified sig-
nificantly more wild-type bacteria attached to the epithelial sur-
face than eaeH mutants (Fig. 5b and c), a finding consistent with
the hypothesis that this outer membrane protein is activated by
and participates in intimate interactions of ETEC with the intes-
tinal epithelium. Collectively, these data suggest that EaeH could
play an important role in the pathogenesis of ETEC infections.
DISCUSSION
The enterotoxigenic Escherichia coli pathotype is diverse. At a
minimum, these organisms share in the ability to produce and
effectively deliver heat-labile and/or heat-stable enterotoxins to
their cognate receptors on intestinal epithelial cells. Shortly after
the discovery of these organisms in patients presenting with chol-
era-like diarrhea (50, 51), the first plasmid-encoded fimbrial col-
onization factors (CFs) were described (10, 52). Over the past 40
years, at least 26 different CFs have been described (13, 28), sug-
gesting that ETEC can use a diverse repertoire of these structures
in its colonization of the small intestine.
These antigens constitute the basis for current vaccine strate-
gies that attempt to encompass the most prevalent CFs (14, 15,
26). However, the antigenic diversity of the CFs and the possibility
that other molecules may participate in intestinal colonization
and toxin delivery have prompted efforts to define additional tar-
get antigens that might augment existing approaches. Recent
studies provide compelling evidence that themolecular pathogen-
esis of ETEC is more complex than had been appreciated previ-
ously and that a number of novel surface or secreted virulence
FIG 1 ETEC eaeH encodes a putative surface-expressed protein. (a) Predicted
structural features with surface-expressed bacterial virulence molecules. Sche-
matic representation of the EaeH protein from ETEC H10407 (33) (accession
GI:71979957 [http://www.ncbi.nlm.nih.gov/protein/AAZ57201.1]) compared to
the prototypical intimin (EaeA)molecule (56, 57) from EPEC strain E2348/69
accession GI:229462841 (http://www.ncbi.nlm.nih.gov/protein/229462841)
depicts the overall domain structure with multiple bacteria immunoglobulin-
like domains (BIg), similar to intimin, as well as an Ig-like fold similar to
filamin (fIg). Intimin also contains a carboxy-terminal C-type lectin domain
and an amino LysM feature pfam01476 (http://www.ncbi.nlm.nih.gov
/Structure/cdd/cddsrv.cgi?uidpfam01476), a putative peptidoglycan-bind-
ing domain. (b) An anti-EaeH immunoblot is shown for outer membrane
preparations from the BL21 expression host strain, BL21AI; the recombinant
strain BL21AI(pSS002); and the ETEC H10407 strain grown in Luria broth.
The schematic depicts the recombinant EaeH-V5-6His molecule cloned in
pSS002 and expressed in BL21AI. (c) EaeH surface expression by ETEC
H10407 grown in L broth is minimal by anti-EaeH flow cytometry. (d) EaeH
surface expression in recombinant strain compared to control, BL21AI. (e)
C-terminal V5 epitope is exposed on the surface of the recombinant,
BL21AI(pSS002).
Contribution of EaeH Protein to ETEC Pathogenesis
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proteins could serve as viable targets for future development ef-
forts (53).
The eaeH gene encoding one of these molecules was originally
identified on the chromosome of ETEC using subtractive hybrid-
ization of the prototype H10407 strain and E. coliK-12 (MG1655)
(33).More recent attempts to identify novel vaccine candidates by
investigation of antigens that are transcriptionally modulated
during pathogen-host interactions also highlighted eaeH, since it
FIG 2 Intestinal epithelial cells induce EaeH surface expression in ETEC. (a) eaeH genes in the chromosomes of the commensal E. coliHS strain, the MG1655
E. coliK-12 strain (interrupted by an IS element (orange), and ETEC strain H10407. (b) Flow cytometry data demonstrating surface expression of EaeH in tissue
culture media and tissue culture media conditioned by growth of Caco-2 intestinal epithelial cells. (c) Time course demonstrating enhanced EaeH production
after H10407 attachment to target epithelial cells. The top panel demonstrates the lack of discernible EaeH expression by ETEC 5min after attachment to Caco-2
cells, whereas after 60 min (middle row) EaeH is detectable on the bacterial surface, and maximal expression is apparent at 120 min (bottom row). (d) EaeH
expression by ETEC strainsH10407 and E24377A at 120min after addition to epithelial cells. Panels from left to right depict DIC images, membrane stains (red),
anti-EaeH antibody detected with Alexa Fluor 488 secondary conjugate (green), and merged membrane-EaeH images. (e) EaeH immunoblotting of E. coli
bacterial lysates following growth in conditionedmedia.On the left are shownH10407 and the eaeHmutant, as positive and negative controls, respectively. ETEC
strains were selected to represent different phylogenetic groups based on whole-genome sequencing (http://gscid.igs.umaryland.edu/wp.php?wpcomparative
_genome_analysis_of_enterotoxigenic_e._coli_isolates_from_infections_of_different_clinical_severity). The Nissle 1917 nonpathogenic commensal isolate is
shown on the right. The arrow indicates the predicted migration of EaeH.
TABLE 3 Comparison of eaeH genes in pathogens and commensal E. colia
Strain Pathotype NCBI protein reference RAST designation
Gene
length (bp) % Identical % Similar
H10407 ETEC AAZ57201.1 .peg.385 4,257
E24377A ETEC YP_001461465 .peg.2865 4,254 92 95
B7A ETEC EDV63917.1 .peg.780 4,254 92 95
MG1655 K-12 AAB18025.1 .peg.302 888 100* 100*
HS Commensal YP_001457122.1 .peg.327 4,254 91 94
Nissle 1917 Commensal CCQ06761 4,251 94 96
UTI89 UPEC YP_539353.1 .peg.433 4,251 94 96
CFT073 UPEC NP_752352.1 .peg.396 4,251 94 96
TX1999 EHEC EGX25301.1 NA 4,254 99 98
EDL933 EHEC NP_286024.1 .peg.332 4,251 93 95
a RAST, Rapid Annotation using Subsytem Technology (63). NA, not applicable. *, The MG1655 (pseudo)gene is truncated by an IS element; the BLAST-P results are thus based on
first 292/296 amino acids.
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was strongly upregulated after contact of ETEC with intestinal
epithelial cells (21).
The results presented here reaffirm these findings and demon-
strate the expression of EaeH by a variety of other ETEC strains.
Moreover, we show that this highly conserved antigen plays a role
in both epithelial cell adhesion in vitro and intestinal colonization
in vivo.
To effectively deliver toxin, ETEC theoretically must find its
way to the small intestine, traverse the protective layer ofmucin in
the intestinal lumen (37), and ultimately engage the epithelial cell.
Previous studies suggest that intimate interaction of ETEC with
target cells is required for effective uptake of heat-labile toxin and
consequent activation of cyclic nucleotides (49). Interestingly, in
the present study, eaeH did not appear to impact overall intestinal
colonization (which measures both bacteria sequestered in the
intestinal lumen and those that are physically attached to the ep-
ithelial surface). However, we found significantly fewer eaeHmu-
tant bacteria directly attached to intestinal epithelial cells, suggest-
ing that this gene is required at a later step in ETEC-host
interactions. These findings are consistent with in vitro studies
suggesting that the activation of eaeH is a late event relative to the
activity of other potential adhesins, including the plasmid-en-
coded CFs, type 1 fimbriae, and the secreted EtpA adhesin (21).
Collectively, the emerging data suggest that both bacterial adhe-
FIG 3 EaeH interacts with the surfaces of intestinal epithelial cells. (a) Binding
of rEaeH to the surface of Caco-2 intestinal epithelial cells. Confocal images of
rEaeH detected with affinity-purified anti-EaeH polyclonal antibody and sec-
ondary AF488 conjugate (green), membrane (CellMask, red), and nuclei
stained with DAPI (blue) are shown. Control samples (BSA) processed in an
identical fashion are shown on the right. (b) rEaeH-V5-6His bound to the
surfaces of latex beads. Beads coated with rEaeH or control beads were ana-
lyzed by flow cytometry to confirm binding of EaeH to the bead surface. (c)
rEaeH-coated beads in a DIC microscopic image (20). (d) Control (BSA-
coated) beads. (e) Numbers of beads per 100 cells after incubation of Caco-2
cells. The values in panel e were compared using two-tailed nonparametric
(Mann-Whitney) testing. (f) SEM image of 1-	m rEaeH-coated latex beads
binding to the Caco-2 epithelial cell surface (10,260) (left panel); SEM image
of 3-	m EaeH-coated beads binding to adjacent Caco-2 cells (3,200) (right
panel). Arrows indicate beads either partially engulfed by cells or engaged by
cellular processes after attachment.
FIG 4 Role of eaeH in bacterial adhesion and toxin delivery. (a) The eaeH gene
is required for optimal adhesion to target intestinal epithelial cells in vitro. (b)
Antibodies raised against EaeH inhibit adhesion. Protein A-purified poly-
clonal antibodies from either preimmune rabbit sera (pre) or postimmune
antisera (post-immune) raised against recombinant EaeH-V5-6His in the in-
dicated amounts were added to Caco-2 monolayers with ETEC H10407. The
percentage of cell-associated bacteria reflects the proportion of bacteria asso-
ciated with the monolayer at the end of 1 h relative to the inoculum. Dashed
horizontal bars represent the geometricmean. (c) EaeH is required for optimal
delivery of heat-labile toxin. cAMPproduction byCaco-2 epithelial cellmono-
layers after infection with either wild-type (wt) or eaeH mutant bacteria.
EaeH refers to the addition of anti-EaeH antibody. A mutant strain with a
deletion of the genes encoding heat-labile toxin (eltAB) is shown as a negative
control.
FIG 5 Impact of EaeH on overall colonization and interaction with intestinal
epithelial cells in vivo. (a) Competition assay studies between the jf2852 eaeH::
Kmr mutant and jf876 (lacZYA::Kmr) wild-type bacteria. The data points rep-
resent competitive index values for individualmice from three replicate exper-
iments shown in different colors. The dashed line represents the geometric
mean. (b) ETEC H10407 (O78:H11) identified by anti-O78 immunofluores-
cence staining (green) adherent to the intestinal surface after oral challenge. (c)
Wild-type (wt) H10407 and eaeH mutant bacteria attached to the epithelial
surface (as shown in panel b). The data represent analyses of three independent
sections of the small intestine from four mice in each group (P  0.012 by
two-tailed Mann-Whitney comparison).
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sion and intestinal colonization are very complex events that in-
volve interactions through fimbrial structures such as the CFs,
secreted proteins such as EtpA, andmore intimate connections to
epithelial cells via EaeH, a highly conserved E. colimembrane pro-
tein.
Although eaeHwas originally identified in ETEC, it is shared by
otherE. colipathotypes, including strains associatedwith extraint-
estinal infections (33, 54, 55), including uropathogenic E. coli
(48). Because E. coli is a normal component of the intestinal flora,
targeting highly conserved antigens that are shared with some
commensal isolates in vaccines could in theory have untoward
consequences. Our studies failed to detect EaeH in the commensal
HS strain under conditions where expression was robust in ETEC
and demonstrated limited production of EaeH in Nissle 1917.
Nevertheless, additional study will be required to determine
whether this can be generalized to other commensal isolates, pref-
erably those which have not undergone serial passage in multiple
laboratories over many years.
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